US 6,967,208

Application 10/245,122 · Granted Nov 22, 2005

Lactam-containing compounds and derivatives thereof as factor xa inhibitors

Estimated expiration

February 3, 2023

Expired 1387 days ago

Confidence: high
High: no high-severity warning was raised, and any terminal disclaimer was resolved to the patents it references.
Earliest effective filing
Sep 17, 2002
+ 20 years
Sep 17, 2022
PTA +139d
Feb 3, 2023
TD cap (US 7,338,963)
Apr 8, 2023
Final
Feb 3, 2023

This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included. Terminal disclaimers can affect PTA (In re Cellect, LLC).

Calculation details

Base term

Filing date
September 17, 2002
Earliest effective filing
September 17, 2002
Issue date
November 22, 2005
PTA
+139 days
Base expiry (before PTA)
September 17, 2022

September 17, 2002 + 20 years = September 17, 2022 + 139 PTA days = February 3, 2023

  • PRO60/324,165 — Provisional — not used for base term

Terminal disclaimers

TD approved1 approved, 12 filed

TD caps expiration to April 8, 2023 (earliest expiring referenced patent: US 7,338,963)

  • US 3,822,000

    Could not resolve calculation details

  • US 10,245,122· Application 15/643,634Capping patent

    Method and device for causing tooth movement

    Filing date
    Jul 7, 2017
    Earliest effective filing
    May 14, 2012
    Issue date
    Apr 2, 2019
    PTA
    0 days
    Calculated expiration
    May 14, 2032

    Continuation of 15/208,401, filed Jul 12, 2016, issued as US 9,814,547

    Continuation of 14/326,069, filed Jul 8, 2014, issued as US 9,387,051

    Continuation of 14/073,778, filed Nov 6, 2013, issued as US 8,770,969

    Continuation of 13/471,099, filed May 14, 2012, issued as US 8,602,777

    Continuation of 13/471,099, filed May 14, 2012, issued as US 8,602,777

    Continuation of 14/073,778, filed Nov 6, 2013, issued as US 8,770,969

    Continuation of 13/471,099, filed May 14, 2012, issued as US 8,602,777

    Continuation of 14/326,069, filed Jul 8, 2014, issued as US 9,387,051

    Continuation of 14/073,778, filed Nov 6, 2013, issued as US 8,770,969

    Continuation of 13/471,099, filed May 14, 2012, issued as US 8,602,777

    May 14, 2012 + 20y = May 14, 2032

  • US 8,188,120· Application 13/101,536Lapsed

    Lactam-containing compounds and derivatives thereof as factor xa inhibitors

    Expired: maintenance fee lapse.

    Filing date
    May 5, 2011
    Earliest effective filing
    May 5, 2011
    Issue date
    May 29, 2012
    PTA
    0 days
    Calculated expiration
    —
  • US 8,470,854· Application 13/444,999Lapsed

    Lactam-containing compounds and derivatives thereof as factor xa inhibitors

    Expired: maintenance fee lapse.

    Filing date
    Apr 12, 2012
    Earliest effective filing
    Apr 12, 2012
    Issue date
    Jun 25, 2013
    PTA
    0 days
    Calculated expiration
    —
  • US 7,338,963· Application 11/198,801Capping patent

    Lactam-containing compounds and derivatives thereof as factor xa inhibitors

    Filing date
    Aug 5, 2005
    Earliest effective filing
    Sep 17, 2002
    Issue date
    Mar 4, 2008
    PTA
    +203 days
    Calculated expiration
    Apr 8, 2023

    Divisional of 10/850,587, filed May 20, 2004, issued as US 6,989,391

    Divisional of 10/245,122, filed Sep 17, 2002, issued as US 6,967,208

    Divisional of 10/245,122, filed Sep 17, 2002, issued as US 6,967,208

    Sep 17, 2002 + 20y + 203d PTA = Apr 8, 2023

Notes (1)

  • [TD_DOCS_TRUNCATED] Found 12 filed TD documents; parsing first 3 only

Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated

You have the date. Your AI can have the file.

Application 10/245,122 · US 6,967,208

PatentReply compiles the prosecution history behind US 6,967,208: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.

One new published application a month is free. The first compile takes a few minutes.

Strategy and filing changes require your approval.

How PatentReply handles an Office Action response →

Permanent link

www.patentreply.ai/tools/patent-expiration/US6967208

Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.